Disease-modifying therapies for spinal muscular atrophy: Family experience, ethical considerations, and the role of social determinants of health
Journal of Neuromuscular Diseases · 2025
DOI: 10.1177/22143602251375561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuromuscular Diseases, 2025. Verfasst von Lena Xiao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada. Hauptthemen laut MEDLINE: Caregivers, Social Determinants of Health, Spinal Muscular Atrophies of Childhood, Family. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cure Spinal Muscular Atrophy Canada.
Abstract (Originalsprache)
Objectives
Spinal muscular atrophy is a progressive neuromuscular condition associated with a complex chronic disease course. An in-depth understanding of the ethical issues and social determinants of health impacting the experiences of families and children living with this condition is critical to improving care delivery. We identified the ethical tensions faced by families caring for children with spinal muscular atrophy as well as the influence of social determinants of health in relation to their perception of novel disease-modifying therapies.
Design
Qualitative study including semi-structured interviews with caregivers of children with spinal muscular atrophy who received disease-modifying therapies. Interviews were audio recorded, transcribed verbatim, and coded. Thematic analysis was utilized to identify ethically salient themes.
Setting
The Hospital for Sick Children (Toronto, Canada)
Results
Fifteen family caregivers of children with spinal muscular atrophy type 1 (n = 5), type 2 (n = 5), and type 3 (n = 5) participated. There were three core themes highlighted including (1) best interests of the child, (2) burden of care and associated moral distress, and (3) parent agency. These experiences were impacted by resources and social determinants of health.
Conclusion
This study provides important insights into the ethical tensions and relevant social determinants of health impacting the caregiver experience. Understanding the experiences of diverse families will allow more appropriate resource distribution, better counselling and supports for families facing unique psychosocial challenges and treatment burdens, and overall improved delivery of patient and family-centered care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada.
- University of Toronto, Toronto, Ontario, Canada.
- Department of Pediatrics, British Columbia Children's Hospital, Vancouver, Canada.
- University of British Columbia, Vancouver, Canada.
- Department of Rehabilitation Services, The Hospital for Sick Children, Toronto, Canada.
- Department of Bioethics, The Hospital for Sick Children, Toronto, Canada.
ORCID-Profile: Lena Xiao, Hernan Gonorazky, Jackie Chiang, Reshma Amin, Melissa D McCradden
Förderung
- Cure Spinal Muscular Atrophy Canada
Zitieren
APA
Xiao, L., Djordjevic, D., Kang, S., Gonorazky, H., Chiang, J., Ambreen, M., Nigro, E., Law, E., Weinstock, L., Amin, R., & McCradden, M. D. (2025). Disease-modifying therapies for spinal muscular atrophy: Family experience, ethical considerations, and the role of social determinants of health. Journal of Neuromuscular Diseases. https://doi.org/10.1177/22143602251375561
Vancouver
Xiao L, Djordjevic D, Kang S, Gonorazky H, Chiang J, Ambreen M, et al. Disease-modifying therapies for spinal muscular atrophy: Family experience, ethical considerations, and the role of social determinants of health. Journal of Neuromuscular Diseases. 2025. doi:10.1177/22143602251375561
BibTeX
@article{Xiao2025,
author = {Xiao, Lena and Djordjevic, Djurdja and Kang, Sohee and Gonorazky, Hernan and Chiang, Jackie and Ambreen, Munazzah and Nigro, Elisa and Law, Eugenia and Weinstock, Lauren and Amin, Reshma and McCradden, Melissa D},
title = {Disease-modifying therapies for spinal muscular atrophy: Family experience, ethical considerations, and the role of social determinants of health},
journal = {Journal of Neuromuscular Diseases},
year = {2025},
doi = {10.1177/22143602251375561}
}
EUVIMED